CA
NKTR icon

Commerzbank Aktiengesellschaft’s Nektar Therapeutics NKTR Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,383
Closed -$370K – 315
2020
Q1 		$370K Sell
1,383
-2,722
-66% -$842K 0.02% 310
2019
Q4 		$1.33M Buy
4,105
+345
+9% +$100K 0.01% 407
2019
Q3 		$1.03M Buy
3,760
+1,983
+112% +$727K 0.01% 530
2019
Q2 		$949K Buy
+1,777
New +$891K 0.01% 623

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Commerzbank Aktiengesellschaft's NKTR Position: Q2 2020 in Review

Commerzbank Aktiengesellschaft sold out of Nektar Therapeutics (NKTR) in Q2 2020, closing a stake of 1,383 shares — an estimated $370K sold.

Commerzbank Aktiengesellschaft first reported a position in NKTR in Q2 2019 and held it in 4 quarters. The position peaked at $1.33M in Q4 2019. 259 funds tracked by Wall St. Rank hold NKTR as of Q2 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Nektar Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 1,383 Nektar Therapeutics shares in Q2 2020, an estimated $370K.
  • Commerzbank Aktiengesellschaft first reported a position in Nektar Therapeutics in Q2 2019 and held it in 4 quarters.
  • Commerzbank Aktiengesellschaft's Nektar Therapeutics position peaked at $1.33M in Q4 2019.
  • 259 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2020, filed 21 Jul 2020.